CIK: 0001910264 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 2, 2022
Total Value ($000): $204,325 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ACLX | ARCELLX INC. | 5,500,007 | $99,440 | 48.7% | $16.72 | -22.8% | COMMON STOCK | 03940C100 |
| DSGN | DESIGN THERAPEUTICS INC | 5,626,476 | $78,771 | 38.6% | $17.17 | -21.3% | COM | 25056L103 |
| NKTX | NKARTA INC. | 1,333,333 | $16,427 | 8.0% | $13.12 | 0.0% | COM | 65487U108 |
| — | EFFECTOR THERAPEUTICS INC | 6,822,114 | $9,687 | 4.7% | $8.28 | — | COM | 28202V108 |